Company: RGNT
Filing Date: 2025-03-11
Form Type: F-1
Source: 0001213900-25-022350
Chunk: 185

Company: REGENTIS BIOMATERIALS LTD.
Filing Date: 2025-03-11
Form: F-1
Chunk 185
---
 table sets forth
information with respect to the beneficial ownership of our Ordinary Shares as of March 10, 2025 by:

| ● | each person or entity known                                              
 by us to own beneficially 5% or more of our outstanding Ordinary Shares; |

| ● | each of our directors and            
 executive officers individually; and |

| ● | all of our directors and       
 executive officers as a group. |

The beneficial ownership of
our Ordinary Shares is determined in accordance with the rules of the SEC and generally includes any shares over which a person exercises
sole or shared voting or investment power, or the right to receive the economic benefit of ownership. For purposes of the table below,
we deem Ordinary Shares issuable pursuant to options or warrants that are currently exercisable or exercisable within 60 days of the date
of this registration statement to be outstanding and to be beneficially owned by the person holding the options for the purposes of computing
the percentage ownership of that person, but we do not treat them as outstanding for the purpose of computing the percentage ownership
of any other person. Percentage of shares beneficially owned before this offering is based on 3,929,378 Ordinary Shares issued and outstanding
as of March 10, 2025. The number of Ordinary Shares deemed issued and outstanding after this offering is based on 909,090 Ordinary Shares
offered hereby but assumes no exercise of the Representative’s over-allotment option.

As of March 10, 2025, and based
on their reported registered office, none of our shareholders were U.S. persons. We have also set forth below information known to us
regarding any significant change in the percentage ownership of our Ordinary Shares by any major shareholders during the past three years.
Except where otherwise indicated, we believe, based on information furnished to us by such owners, that the beneficial owners of the Ordinary
Shares listed below have sole investment and voting power with respect to such shares.

Following the closing of
this offering, all of our shareholders, including the shareholders listed below, will have the same voting rights attached to their Ordinary
Shares, and neither our principal shareholders nor our directors and executive officers will have different or special voting rights
with respect to their Ordinary Shares. See “Description of Share Capital—Voting Rights.” A description of any material
relationship that our principal shareholders have had with us or any of our predecessors or affiliates within the past three years is
included under “Certain Relationships and Related Party Transactions.”

Unless otherwise noted below,
the